Common questions about Tanakan (FAQ)
Q: How quickly can someone expect to notice an effect from Tanakan?
Official information indicates that the extract's therapeutic effects are generally observed after repeated treatment and are not immediate. Regulatory guidelines indicate that continued use is typically re-evaluated after a minimum course of at least 8 weeks.
Q: Is it normal to feel a mild stomach upset when starting Tanakan?
Yes, official safety documentation lists upset stomach as a potential adverse reaction to the extract. Other documented gastrointestinal effects include nausea, vomiting, and diarrhea.
Q: Can people with liver issues use Tanakan?
Official regulatory documents do not list chronic liver issues as a formal contraindication. Official documentation notes that severe or uncontrolled hepatic disorders were generally criteria for exclusion from clinical studies.
Q: Can I take Tanakan if I have diabetes?
The official regulatory documents do not list diabetes mellitus as a formal contraindication for the use of this standardized extract.
Q: Does Tanakan interact with common pain relievers like ibuprofen?
Official regulatory documents advise that co-administration with antiplatelet drugs should be avoided due to the increased risk of bleeding. This category of medicines includes many common pain relievers such as ibuprofen.
Q: Can I use Tanakan if I am lactose intolerant?
The coated tablet formulation contains lactose and is therefore contraindicated for individuals with specific sugar malabsorption issues, including lactase deficiency. The product is also available in an oral solution form.
Q: What happens if a dose of Tanakan is missed?
Regulatory procedure states that if a scheduled dose is missed, a patient should not take a double dose to compensate for the omission. The patient is advised to take the next scheduled dose at the usual time.
Q: Is Tanakan the same as other Ginkgo Biloba supplements?
No. Official documentation defines Tanakan (EGb 761) as a standardized pharmaceutical-grade extract with a precisely controlled composition. Other Ginkgo Biloba supplements are typically not standardized to the same specifications and are not considered pharmaceutically equivalent.
Q: Does Tanakan affect blood pressure?
Official documentation lists orthostatic hypotension (a drop in blood pressure when standing up) as a potential adverse reaction. Some studies have also examined an effect on reducing the rise in blood pressure associated with stress.
Q: Can Tanakan be taken alongside anti-anxiety medications?
Regulatory reviews indicate that at the maximum recommended dose, the risk of a significant pharmacokinetic interaction with many synthetic drugs, including those for CNS function, has not been demonstrated. The oral solution contains ethanol, a factor described in the product information when used alongside CNS depressants.
Q: Are there different forms of Tanakan available, like liquid or capsules?
Official product information states that Tanakan is available as coated tablets and an oral solution (40 mg/mL). It is not typically marketed in the capsule form.
Q: Why do official sources sometimes mention Tanakan for vertigo?
Official regulatory agencies in several countries have authorized its use for the symptomatic treatment of vertigo that is of vascular or involutional origin (related to aging). This is based on the extract's documented effects on circulation and neuronal function.
Q: What is the difference between Tanakan and pure Ginkgo extract?
Tanakan is a standardized, pharmaceutical-grade extract (EGb 761) with a quality-controlled composition defined by regulatory standards. Pure Ginkgo extract usually refers to non-standardized material that may vary widely in its content of active components.
Q: Do any studies look at Tanakan's use for tinnitus (ringing in the ears)?
Yes, the extract EGb 761 has been the subject of randomized, placebo-controlled clinical trials examining its potential use in the treatment of tinnitus (ringing in the ears).
Q: Is the extract in Tanakan standardized?
Yes, the active substance is defined as a Standardized Extract (EGb 761). This designation means the manufacturing process is regulated to ensure a consistent, defined quantity of active therapeutic components in every batch.
Q: Why do people use Tanakan for balance issues?
The extract's authorized use includes the symptomatic treatment of vertigo that is due to vascular or age-related origin. This regulatory indication directly addresses common patient concerns related to balance issues.
Q: Is there any research on Tanakan and eyesight?
Yes, research has been conducted and continues to examine the use of the EGb 761 extract for specific conditions affecting eyesight, such as Diabetic Retinopathy. The existence of these trials is recorded in government-run databases.
Q: Can people with kidney problems take Tanakan?
Official regulatory documentation does not list chronic kidney (renal) issues as a formal contraindication. Official documentation notes that severe renal disorders were generally criteria for exclusion from clinical studies.
Q: Why are the use conditions for Tanakan different in various countries?
Drug regulatory agencies in different regions (e.g., Europe, China, South America) assess and authorize the extract for different uses based on local clinical data and traditions. This leads to variations in official use conditions and classifications internationally.
Q: How is the quality of the Tanakan extract assured?
The production of the standardized extract is subject to rigorous regulatory standards. This includes the Good Manufacturing Practice (GMP) and Good Agricultural and Collection Practice (GACP) requirements set by authorities like the European Medicines Agency (EMA).
Q: Does taking Tanakan require regular monitoring by a doctor?
Official guidelines mandate that the decision to continue treatment beyond a duration of three months should be re-evaluated if no satisfactory response has been observed. The necessity of continued use is typically reassessed following this re-evaluation period.
Q: Is Tanakan mentioned in any government health guidelines?
Yes, the Committee on Herbal Medicinal Products of the European Medicines Agency (EMA) has approved the extract's well-established use for the treatment of age-related cognitive impairment.
Q: Can Tanakan cause skin reactions or itching?
Yes, the official safety profile documents allergic reactions affecting the skin, including rash, itching, and hives, as possible adverse effects.
Q: Does Tanakan interact with birth control pills?
Official documentation states that the extract may cause CYP3A4 induction, which may theoretically decrease the concentration of sensitive substrates, such as some oral contraceptives. However, a clinically relevant interaction potential has generally not been shown at recommended doses.
Q: Does Tanakan have sugar or artificial sweeteners?
The coated tablets contain lactose (a sugar). Specific artificial sweeteners are not typically listed in the core regulatory summary for either the tablets or the oral solution.
Q: Is it true that Tanakan is sometimes used for relief of cold feet and hands?
The extract has been researched for use in peripheral circulatory issues, which can involve symptoms like cold extremities. Studies have examined its effect on improving pain-free walking distance in related conditions like intermittent claudication.
Q: What kind of studies have been done on Tanakan?
Studies on the standardized extract primarily include randomized controlled trials (RCTs) and meta-analyses. These studies have investigated its use across three main areas: cognitive symptoms, vertigo, and peripheral circulatory issues.
Q: Is Tanakan's effectiveness backed by large clinical trials?
Research has included randomized controlled trials (RCTs) to assess the extract’s effects. However, regulatory overviews of the evidence often note mixed findings and the inconsistency of results across every large-scale trial.
